Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
HY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2018 | Fushoukang | Angel Round | - |
10/2018 | Cloudbreak Therapeutics | Series A | 15.8M |
4/2020 | ChosenMed | Series B | 14M |
4/2017 | UEG Medical | Series A | 1.4M |
3/2022 | Chinagene Tech | Series A | 15.8M |
8/2019 | Zhizu Tech | Series A | 14.2M |
9/2018 | Fushoukang | Series A | - |
7/2017 | Symbow Medical | Series A | 17.8M |
1/2022 | Yijian Health | Seed Round | - |
5/2019 | MFA | Series A | - |
1/2018 | Laviana Pharma | Series B | 15M |
3/2022 | Chinagene Tech | Series A | 0 |
1/2022 | Yijian Health | Seed Round | - |
4/2020 | ChosenMed | Series B | 0 |
8/2019 | Zhizu Tech | Series A | 0 |
5/2019 | MFA | Series A | - |
10/2018 | Cloudbreak Therapeutics | Series A | 0 |
9/2018 | Fushoukang | Series A | - |
4/2018 | Fushoukang | Angel Round | - |
1/2018 | Laviana Pharma | Series B | 0 |
7/2017 | Symbow Medical | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|